entertainment -WSS

entertainment

author：hotspot 2025-09-06 04:42:00 - browse：15

Lung cancer under microscope — coverage from STAT — Lung cancer Adobe

CHICAGO — Delfi Diagnostics, a company seeking to develop liquid biopsy tests to help screen for lung cancer, published a scientific paper on Monday describing key aspects of the test and unveiled the design of a key clinical trial.

Delfi also announced that the Merck Global Health Innovation Fund, the VC arm of the drug giant, has made an investment of an undisclosed amount in the company.

Unlike Grail, a unit of Illumina, or Exact Sciences, which seeks to develop a blood test that can be used to screen for multiple types of cancer, Delfi is focusing on a single disease — lung cancer — in which the utility of screening with existing technology is not in dispute. Using low-dose CT scans to detect lung cancer is considered an established technology for people at higher risk of lung cancer. However, far too few people get screened.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： Robert Kennedy Jr.'s presidential campaign attracts GOP

WSS

Maui's cultural, historic landmarks damaged in the devastating wildfires

Vivek Ramaswamy, who's embraced Trump on the campaign trail, condemned him after Jan. 6

Friends ask where James Watson's attitudes about race came from

Emergent cuts jobs, executive role in business shake

US soldier in North Korean custody after crossing DMZ line

Why failed clinical trials don’t always spell doom for a new drug

hotspot

entertainment

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

hotspot

Jerome Adams on the need for new antivirals for Covid

The best solution to the drug shortages problem

Walensky prepares to leave CDC — and Congress — behind

Phoenix breaks record with 19 consecutive days above 110 degrees Fahrenheit

As demand for Covid shots wanes, Moderna seeks its next success

What we know about the American soldier detained in North Korea

Dobbs anniversary: the lost opportunity of abortion as health care

Listen: Merck v. USA, the best of ASCO, and Leqembi at the FDA

Psychedelics group wrestles with new pharma identity

Man killed during FBI raid in connection with threats against Biden, other officials

entertainment

Hawaii wildfires fueled by Hurricane Dora's winds prompt evacuations

Why failed clinical trials don’t always spell doom for a new drug

Q&A: Figuring out how songbirds sing may lead to better understanding of how humans learn

Biden administration sends mixed signals on US soldier who crossed into North Korea

Maui's cultural, historic landmarks damaged in the devastating wildfires

UK homeowners get some respite as inflation falls by more than anticipated to a 15

focus

hotspot

focus

entertainment